Small Cell Lung Cancer: Limited Disease

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-642-18698-1_24
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung carcinoma

  2002cited by this paper
• Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.

  2002cited by this paper
• Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation.

  2002cited by this paper
• Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).

  2001cited by this paper
• Multicenter phase II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung cancer.

  2001cited by this paper
• Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control.

  2001cited by this paper
• Cisplatin and etoposide (EP-regimen) is superior to cyclophosphamide, epirubicin, and vincristin (CEV-regimen) in small cell lung cancer: results from a randomized phase III trial with 5 years follow-up

  2001cited by this paper
• A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.

  2000cited by this paper
• Chest radiotherapy in limited-stage small cell lung cancer: facts, questions, prospects.

  2000cited by this paper
• Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.

  2000cited by this paper
• A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma

  1999cited by this paper
• Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma.

  1999cited by this paper
• Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study.

  1999cited by this paper
• Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

  1999cited by this paper
• Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide.

  1999cited by this paper
• The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer.

  1999cited by this paper
• Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: evidence for inherent interindividual variation.

  1998cited by this paper
• Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.

  1998cited by this paper
• Bases biologiques de l'association chimio-radiotherapie. Applications aux cancers du poumon

  1997cited by this paper
• Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study.

  1997cited by this paper
• Treatment of small cell lung cancer: the state of the art.

  1997cited by this paper
• Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study.

  1997cited by this paper
• Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group.

  1997cited by this paper
• Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy.

  1994cited by this paper
• Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): a consensus report.

  1994cited by this paper
• A randomized trial of delayed thoracic radiotherapy in complete responder patients with small-cell lung cancer. Petites Cellules Group.

  1993cited by this paper
• Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

  1993cited by this paper
• Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer.

  1993cited by this paper
• A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

  1992cited by this paper
• Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis.

  1992cited by this paper
• Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer.

  1992cited by this paper
• Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.

  1992cited by this paper
• Late consolidative radiation therapy in the treatment of limited‐stage small cell lung cancer

  1991cited by this paper
• Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small-cell lung carcinoma: an update.

  1989cited by this paper
• The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized Trial.

  1988cited by this paper
• Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study.

  1987cited by this paper
• Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung.

  1987cited by this paper
• Superior vena caval obstruction syndrome in small cell lung cancer

  1986cited by this paper
• A randomized study: small cell anaplastic lung cancer treated by combination chemotherapy and adjuvant radiotherapy.

  1980cited by this paper
• Prognostic value of the superior vena cava syndrome as the presenting sign of small cell anaplastic carcinoma of the lung.

  1980cited by this paper
• "The state of the art" toward defining the role of radiation therapy in the management of small cell bronchogenic carcinoma.

  1980cited by this paper
• Role of radiation therapy in combination with chemotherapy in extensive oat cell cancer of the lung: a randomized study.

  1977cited by this paper
• Letter: Immunosuppression by linoleic acid.

  1975cited by this paper
• Five-year follow-up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus.

  1969cited by this paper

• Prognostic Factors in Patients with Terminal Stage Lung Cancer

  2014cites this paper
• Epidemiology of lung cancer prognosis: quantity and quality of life.

  2009cites this paper
• Positive Psychological Well-Being and Mortality: A Quantitative Review of Prospective Observational Studies

  2008cites this paper
• A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer.

  2008cites this paper
• Narratives of Exceptional Survivors Who Work with Aboriginal Healers

  2008cites this paper
• Controversies in the timing of chest radiotherapy: E11-02

  2007cites this paper
• Palliative Thoracic Radiotherapy in Locally Advanced Non-small Cell Lung Cancer: Can Quality-Of-Life Assessments Help in Selection of Patients for Short- or Long-Course Radiotherapy?

  2006cites this paper
• Implementation and evaluation of the Edmonton Symptom Assessment Scale in gyne-oncology patients admitted to acute care : a pilot project

  2005cites this paper
• Prognostic value of depressive coping and depression in survival of lung cancer patients

  2004cites this paper
• Quality of life scores: An independent prognostic variable in a general population of cancer patients receiving chemotherapy

  2004cites this paper
• A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer.

  2004cites this paper
• Radiotherapie bei limited SCLC

  2004influential citation
• Rehabilitation of Patients with Neurologic Tumors and Cancer-Related Central Nervous System Disabilities

  2002cites this paper
• The health-related quality of life and survival of small-cell lung cancer patients: Results of a companion study to CALGB 9033

  2002cites this paper
• Quality-of-Life Assessment in Oncology

  2002cites this paper
• Small cell lung cancer.

  1987cites this paper